The study suggests including hs-CRP, Apo-B, Lp(a), non-HDL-C, and oxidized LDL in routine screening for early CAD detection. Despite their proven effectiveness, these biomarkers are not widely used. Therefore, integrating early biomarker screening with lifestyle modifications can enhance risk assessment and improve treatment outcomes.